This is the authors' abstract. We don't add key points for this paper.
This paper examines venture capital (VC) syndication strategies employed to mitigate the risks of the COVID-19 pandemic, particularly in strong versus weak institutional conditions. This study utilizes a comprehensive dataset of 41,008 VC deals across 74 economies between 1 January 2018 and 30 June 2022. Using a multi-level mixed-method approach, we demonstrate that during the COVID-19 pandemic VCs avoided syndication as a risk-mitigation strategy in seed and early-stage VC investments particularly in regions with strong legal frameworks where syndications were more common pre-pandemic. However, the tendency of VC investors to avoid syndication under heightened risk was moderated by founder-CEO leadership; VCs selectively embraced syndication in founder-led firms. The novel contribution of this study is that while VC investors typically avoided syndications to mitigate agency risks in high-risk settings, during the pandemic they instead rallied around founder CEOs – viewed as risk buffers – in syndicated deals, a strategy previously observed in early-stage and emerging market investments. The study also reveals that VCs avoided investment in larger deals during the COVID-19 pandemic, consistent with efforts to mitigate risk.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: